Eptifibatide provides additional platelet inhibition in Non–ST-Elevation myocardial infarction patients already treated with aspirin and clopidogrel
Authors:
- Miles DalbyMDMiles Dalby
- Gilles MontalescotGMGilles Montalescot
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Comparison of effects on markers of blood cell activation of enoxaparin, dalteparin, and unfractionated heparin in patients with unstable angina pectoris or non–ST-segment elevation acute myocardial infarction (the ARMADA study)The American Journal of Cardiology, 2003
- Molecular bases of defective signal transduction in the platelet P2Y 12 receptor of a patient with congenital bleedingProceedings of the National Academy of Sciences, 2003
- Platelet Reactivity in Coronary Ostial Blood: A Reflection of the Thrombotic State Accompanying Plaque Rupture and of the Adequacy of Anti-Thrombotic TherapyJournal of Thrombosis and Thrombolysis, 2001
- Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment ElevationNew England Journal of Medicine, 2001
- Differential antiplatelet efficacy for various GPIIb/IIIa antagonists Role of plasma calcium levelsCardiovascular Research, 2000
- Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 1998
- Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial InfarctionNew England Journal of Medicine, 1998
- Effect of Ca 2+ on GP IIb-IIIa Interactions With IntegrilinCirculation, 1997
- Estimation of the Box Correction for Degrees of Freedom from Sample Data in Randomized Block and Split-Plot DesignsJournal of Educational Statistics, 1976
- Variability in the Aggregation of Human Platelets by adrenalineNature, 1964